Filtered By:
Therapy: Dialysis
Vaccination: Pneomococcal Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 46 results found since Jan 2013.
Preparation, Purification and Performance Evaluation of Polyclonal Antibody Against SARS-CoV-2 Produced in Rat
CONCLUSION: Herein, we presented a simple and cheap method for the purification of whole viral particles with relatively high quality. The results verified that these antigens could elicit a good immune response in the rat. The obtained pAbs showed a good specificity toward SARS-CoV-2 antigens. Accordingly, this study proposes a promising method for viral vaccine development.PMID:37646054 | PMC:PMC10460799 | DOI:10.34172/apb.2023.059
Source: Adv Data - August 30, 2023 Category: Epidemiology Authors: Fatemeh Yaghoobizadeh Mohammad Roayaei Ardakani Mohammad Mehdi Ranjbar Mohammad Khosravi Hamid Galehdari Source Type: research
Pneumococcal vaccination coverage at the initiation of chronic dialysis, and its association with mortality during the first year
CONCLUSIONS: Pneumococcal immunization with PCV13 followed by PPSV23, or with PCV13 alone, but not with PPSV23 alone, is independently associated with decreased one year-mortality in patients who start dialysis.PMID:37179164 | DOI:10.1016/j.vaccine.2023.05.003
Source: Vaccine - May 13, 2023 Category: Allergy & Immunology Authors: Élodie Pierre Ad élaïde Pladys Sahar Bayat-Makoei Pierre Tattevin C écile Vigneau Source Type: research
Influenza and pneumococcal vaccination and COVID-19 in kidney transplant patients
CONCLUSION: The observations made throughout this study suggest that influenza and pneumococcal vaccination in transplant patients may reduce the risk of COVID-19 disease and provide additional benefits during the pandemic period.PMID:35963562 | PMC:PMC9365519 | DOI:10.1016/j.trim.2022.101693
Source: Transplant Immunology - August 13, 2022 Category: Transplant Surgery Authors: Atilla Satir Alparslan Ersoy Hakan Demirci Murat Ozturk Source Type: research
Peritoneal dialysis in the era of COVID-19: experience of a Tunisian center
J Nephrol. 2022 Aug 1. doi: 10.1007/s40620-022-01396-9. Online ahead of print.ABSTRACTThe COVID-19 pandemic has transformed the health landscape by hampering the management of patients with chronic diseases. Providing optimal healthcare has become a critical issue, especially for patients with end-stage renal disease (ESRD) receiving in-center dialysis. Peritoneal Dialysis (PD) has the advantage of being a home-based therapy. Several papers about COVID-19 in the chronic kidney disease (CKD) population have been published, but few studies focused on the PD population, with limited case series. In this paper, we share our st...
Source: Journal of Nephrology - August 1, 2022 Category: Urology & Nephrology Authors: Samarra Badrouchi Samia Barbouch Asma Bettaieb Nada Sellami Mariem Hajji Taieb Ben Abdallah Fethi Ben Hamida Amel Harzallah Ezzedine Abderrahim Source Type: research
Early infectious risk in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis according to remission-induction therapy
CONCLUSIONS: Within 6 months of RIT, rates of survival without severe infection were similar in newly diagnosed ANCA-positive AAV patients treated with RTX or CYC, but survival rates without infections of any severity appeared to be lower with RTX treatment.PMID:35048797 | DOI:10.1080/03009742.2021.2001929
Source: Scandinavian Journal of Rheumatology - January 20, 2022 Category: Rheumatology Authors: M G érard H de Boysson R Morello N Martin-Silva A-C Leroux A Dumont G Maign é J Boutemy K Khoy D Mariotte T Lobbedez A Aouba S Deshayes Source Type: research
